1 option
Counterfeit controlled prescription drug availability in Pennsylvania and Delaware.
- Format:
- Book
- Government document
- Series:
- DEA intelligence report ; 035-20.
- DEA intelligence report ; DEA-PHL-DIR-035-20
- Language:
- English
- Subjects (All):
- Drug adulteration.
- Product counterfeiting--Pennsylvania.
- Product counterfeiting.
- Product counterfeiting--Delaware.
- Fentanyl--Pennsylvania.
- Fentanyl.
- Fentanyl--Delaware.
- Delaware.
- Pennsylvania.
- Physical Description:
- 1 online resource (8 pages) : color illustrations, color maps.
- Place of Publication:
- [Washington, D.C.] : Drug Enforcement Administration, Strategic Intelligence Section, 2020.
- Notes:
- "September 2020."
- Unclassified.
- Description based on online resource, PDF version; title from cover (DEA website, viewed Dec. 14, 2020).
- OCLC:
- 1226746120
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.